Literature DB >> 19082546

MCF-7 breast carcinoma cells express ryanodine receptor type 1: functional characterization and subcellular localization.

Carlos Saldaña1, Mauricio Díaz-Muñoz, Anaid Antaramián, Adriana González-Gallardo, Pablo García-Solís, Verónica Morales-Tlalpan.   

Abstract

Breast carcinoma-derived MCF-7 cells are frequently used in biomedical research. However, few reports exist regarding the characterization of signaling mechanisms in these cancerous cells involved in intracellular Ca(2+) dynamics. Consequently, the aim of these experiments was to characterize the ryanodine receptor/Ca(2+) release channel (RyR) present in MCF-7 cells. Ryanodine (100 nM), cADPR (5 microM), and caffeine (10 mM) promoted cytoplasmic Ca(2+) mobilization; in contrast, ryanodine at inhibitory concentration (100 microM) decreased the basal Ca(2+) level. Fluorescent probes demonstrated that RyR is located mainly in endomembranes. Some degree of co-localization with inositol trisphosphate receptor (IP(3)R) was observed, whereas coincidence with thapsigargin-sensitive Ca(2+)-ATPase (SERCA) was more limited. Molecular cloning resulted in the detection exclusively of RyR isoform 1. For the first time, it is shown that MCF-7 cells express functional RyR.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19082546     DOI: 10.1007/s11010-008-9962-7

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  39 in total

1.  Functional expression of the calcium release channel from skeletal muscle ryanodine receptor cDNA.

Authors:  R Penner; E Neher; H Takeshima; S Nishimura; S Numa
Journal:  FEBS Lett       Date:  1989-12-18       Impact factor: 4.124

2.  Ryanodine receptor expression correlates with tumor grade in breast cancer.

Authors:  Mansoor Abdul; Sian Ramlal; Naseema Hoosein
Journal:  Pathol Oncol Res       Date:  2008-04-23       Impact factor: 3.201

3.  Functional IP3- and ryanodine-sensitive calcium stores in presynaptic varicosities of NG108-15 (rodent neuroblastoma x glioma hybrid) cells.

Authors:  P Rondé; J J Dougherty; R A Nichols
Journal:  J Physiol       Date:  2000-12-01       Impact factor: 5.182

4.  Polymethoxylated flavones induce Ca(2+)-mediated apoptosis in breast cancer cells.

Authors:  Igor N Sergeev; Shiming Li; Julie Colby; Chi-Tang Ho; Slavik Dushenkov
Journal:  Life Sci       Date:  2006-09-15       Impact factor: 5.037

5.  K+ channels and the intracellular calcium signal in human melanoma cell proliferation.

Authors:  A Lepple-Wienhues; S Berweck; M Böhmig; C P Leo; B Meyling; C Garbe; M Wiederholt
Journal:  J Membr Biol       Date:  1996-05       Impact factor: 1.843

6.  Regulation of Ca2+ mobilization by prolactin in mammary gland cells: possible role of secretory pathway Ca2+-ATPase type 2.

Authors:  Utchariya Anantamongkol; Haruo Takemura; Tuangporn Suthiphongchai; Nateetip Krishnamra; Yoshiyuki Horio
Journal:  Biochem Biophys Res Commun       Date:  2006-11-20       Impact factor: 3.575

7.  Fluorescent conjugates of brefeldin A selectively stain the endoplasmic reticulum and Golgi complex of living cells.

Authors:  Y Deng; J R Bennink; H C Kang; R P Haugland; J W Yewdell
Journal:  J Histochem Cytochem       Date:  1995-09       Impact factor: 2.479

8.  ATP modulation of mitogen activated protein kinases and intracellular Ca2+ in breast cancer (MCF-7) cells.

Authors:  Paola Scodelaro Bilbao; Ricardo Boland; Ana Russo de Boland; Graciela Santillán
Journal:  Arch Biochem Biophys       Date:  2007-07-31       Impact factor: 4.013

9.  Biochemical characterization, distribution and phylogenetic analysis of Drosophila melanogaster ryanodine and IP3 receptors, and thapsigargin-sensitive Ca2+ ATPase.

Authors:  Olivia Vázquez-Martínez; Rafael Cañedo-Merino; Mauricio Díaz-Muñoz; Juan R Riesgo-Escovar
Journal:  J Cell Sci       Date:  2003-06-15       Impact factor: 5.285

10.  Human breast cancer cell growth inhibition and deregulation of [Ca2+]i by estradiol.

Authors:  P T Jain; B F Trump
Journal:  Anticancer Drugs       Date:  1997-03       Impact factor: 2.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.